First was LoveLetter, then came NewLove, and then it was Stages. In the space of six weeks, three viruses and a few of their variants caused many organizations to stop, look and listen to the virus problem as serious amounts of money were spent to deal with these latest virus threats. For some organizations, it was also a time to question their Anti-Virus suppliers as to the efficacy of the product being supplied. Given that the Anti-Virus approaches used did not in many cases prevent the damage from being done, it makes sense to review what technology is being used and what we can expect to see from Anti-Virus companies in the future.
Read Entire Paper
E-Mail Link
Your IP address will be sent with this e-mail
